Transformational Impact of Nanomedicine: Reconciling Outcome with Promise

被引：12
作者：
Nel, Andre E. [1 ,2 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div NanoMed, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA
来源：
NANO LETTERS | 2020年 / 20卷 / 08期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1021/acs.nanolett.0c02738
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：5601 / 5603
页数：3
相关论文
共 10 条
  • [1] [Anonymous], 2018, NANOMEDICINE MARKET
  • [2] Infoholic Research, NAN MARK GROW CAGR 1
  • [3] Mirkin C.A., 2011, NANOTECHNOLOGY RES D
  • [4] National Academies of Sciences Engineering and Medicine, 2020, QUADR REV NAT NAN IN
  • [5] Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological Approach and High-Throughput Screening
    Nel, Andre
    Xia, Tian
    Meng, Huan
    Wang, Xiang
    Lin, Sijie
    Ji, Zhaoxia
    Zhang, Haiyuan
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2013, 46 (03) : 607 - 621
  • [6] Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
  • [7] Subcommittee on Nanoscale Science Engineering and Technology Committee on Technology of the National Science and Technology Council., 2019, NAT NAN IN PRES 20 S
  • [8] Does Nanomedicine Have a Delivery Problem?
    Torrice, Michael
    [J]. ACS CENTRAL SCIENCE, 2016, 2 (07) : 434 - 437
  • [9] U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2018, LIP DRUG PROD CHEM M
  • [10] Ventola C Lee, 2017, P T, V42, P742
1